TMCnet News

CinCor Pharma to Present at Upcoming Piper Sandler and Evercore ISI Investor Conferences
[November 22, 2022]

CinCor Pharma to Present at Upcoming Piper Sandler and Evercore ISI Investor Conferences


WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that company management will present at the following investor conferences in November:

Event:Piper Sandler 34th Annual Healthcare Conference
Date:November 29 – December 1, 2022
Location:Lotte New York Palace in New York, New York
Presentation:Tuesday, November 29, 2022 at 1:30pm EST
Webcast:https://event.webcasts.com/starthere.jsp?ei=1585686&tp_key=3261cabcd6
  
Event:Evercore ISI 5th Annual HealthCONx Conference
Date:November 30 – December 1, 2022
Location:Virtual
Presentation:Thursday, December 1, 2022 at 3:30pm EST
Webcast:https://wsw.com/webcast/evercore29/cinc/2336910



The CinCor management team will participate in one-on-one investor meetings during these events. Investors interested in meeting with CinCor at the conference should contact their Piper Sandler or Evercore ISI representative. An archived replay of the presentations will be available for 90 days at CinCor.com/events.

About CinCor
CinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism.


Contacts: Investors:
Michael KalbBob Yedid
CinCor Pharma, Inc.LifeSci Advisors
EVP and CFO  [email protected]

Primary Logo


[ Back To TMCnet.com's Homepage ]